Twenty-seven states and the District of Columbia have sued the bankrupt genetic testing company 23andMe in an effort to block ...

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

Twenty-seven states and Washington, D.C., have filed a lawsuit to block the sale of customers’ DNA and data without their ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...

Twenty-eight states argue that 23andMe must secure explicit, informed consent from all 15 million affected users before ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...

States sue to halt Regeneron's 23andMe acquisition, citing privacy concerns over user DNA data, as a court-ordered report on ...

Over half of all U.S. states are suing to block the sale of 23andMe's personal genetic data, which would be done without ...

New York and more than two dozen other U.S. states sued 23andMe to challenge the sale of its customers' private information ...

More than two dozen states, along with the District of Columbia, are suing biotechnology company 23andMe over plans to ...

Dozens of States Sue to Block the Sale of 23andMe Personal Genetic Data Without Customer Consent PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit ...